Investigational Drug Information for Bitopertin
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Bitopertin?
Bitopertin is an investigational drug.
There have been 11 clinical trials for Bitopertin.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2010.
The most common disease conditions in clinical trials are Schizophrenia, Thalassemia, and Compulsive Behavior. The leading clinical trial sponsors are Hoffmann-La Roche, Karolinska Institutet, and Niuvanniemi Hospital.
Summary for Bitopertin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 156 |
| WIPO Patent Applications | 87 |
| Japanese Patent Applications | 38 |
| Clinical Trial Progress | Phase 3 (2010-12-01) |
| Vendors | 56 |
Recent Clinical Trials for Bitopertin
| Title | Sponsor | Phase |
|---|---|---|
| Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP | Disc Medicine, Inc | Phase 2 |
| A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia | Hoffmann-La Roche | Phase 2 |
| A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers. | Hoffmann-La Roche | Phase 1 |
Clinical Trial Summary for Bitopertin
Top disease conditions for Bitopertin
Top clinical trial sponsors for Bitopertin
US Patents for Bitopertin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
